cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2007; 49:1753-1762, doi:10.1016/j.jacc.2007.01.067 (Published online 13 April 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davidson, M. H.
Right arrow Articles by Robinson, J. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Davidson, M. H.
Right arrow Articles by Robinson, J. G.

Safety of Aggressive Lipid Management

Michael H. Davidson, MD, FACC*,* and Jennifer G. Robinson, MD, MPH{dagger}

* Radiant Research, Rush University Medical Center, Chicago, Illinois
{dagger} University of Iowa, Iowa City, Iowa


Figure 1
View larger version (11K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Incidence of Muscle Symptoms With CK Elevations >10x ULN and Rhabdomyolysis

Included only cardiovascular event trials for which these data were reported (2–4,7,25–27). CK = creatine kinase; LDL = low-density lipoprotein; OR = odds ratio; ULN = upper limit of normal.

 

Figure 2
View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Incidence of ALT Elevations >3x ULN on 2 or More Consecutive Occasions

Included only cardiovascular event trials for which these data were reported (2–4,7). Abbreviations as in Figure 1.

 




 
  cardiology careers collections past issues search home